- RecruitingPHASE1, PHASE2
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
This study is testing new combination medicines, BNT326 and BNT327, for people with advanced non-small cell lung cancer. It aims to find a safe dose and see how well they work, both for those who've had previous treatments and those who haven't.
For: Non-small Cell Lung CancerUnited States · Australia · China - RecruitingPHASE1, PHASE2
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
This study is testing a new treatment called BNT326, sometimes with other medicines, for people with advanced cancers. It aims to see if these treatments are safe, how well they work, and what dose is best.
For: Advanced Solid TumorUnited States · Australia · Belgium